[177Lu]Lu-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study

Journal:

The Lancet Oncology

Published:

2026-03-30

DOI:

10.1016/s1470-2045(25)00762-4

Affiliations:

13

Authors:

21

Go to article

Institutions	Authors	Share
Radboud University Medical Centre (Radboudumc), RU, Netherlands	10.500000 10.500000	0.50
Amsterdam UMC, Netherlands	3.000000	0.14
University Medical Center Groningen (UMCG), RUG, Netherlands	2.500000	0.12
German Oncology Center (GOC), Cyprus	2.000000	0.10
Röntgeninstitut, Germany	1.000000	0.05
Prosper Prostate Cancer Clinics, Netherlands	1.000000	0.05
Erasmus University Medical Center (Erasmus MC), Netherlands	0.500000	0.02
Canisius-Wilhelmina Hospital (CWZ), Netherlands	0.500000	0.02

Interested in Oncology and Carcinogenesis?